Alnylam Pharmaceuticals Stock Forecast

Buy candidate since Jun 25, 2026

The Alnylam Pharmaceuticals stock price fell by -0.303% on the last day (Thursday, 25th Jun 2026) from $294.06 to $293.17. During the last trading day the stock fluctuated 2.72% from a day low at $290.45 to a day high of $298.35. The price has been going up and down for this period, and there has been a 0.67% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -169 thousand shares and in total, 1 million shares were bought and sold for approximately $324.21 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -12.40% during the next 3 months and, with a 90% probability hold a price between $241.17 and $266.86 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ALNY Signals & Forecast

The Alnylam Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $286.36 and $292.70. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has risen 5.42%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Alnylam Pharmaceuticals stock

Alnylam Pharmaceuticals finds support from accumulated volume at $292.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $7.90 between high and low, or 2.72%. For the last week, the stock has had daily average volatility of 3.36%.

Our recommended stop-loss: $280.20 (-4.42%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 4 days ago.)

Trading Expectations (ALNY) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Alnylam Pharmaceuticals to open at $293.99, and during the day (based on 14 day Average True Range), to move between $288.17 and $298.17, which gives a possible trading interval of +/-$10.01 (+/-3.47%) up or down from last closing price. If Alnylam Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 3.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $292.16 (0.34%) than the resistance at $295.63 (0.84%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Alnylam Pharmaceuticals stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.693 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 26, 2026 - $293.99 ( 0.279%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk